India’s Healthcare Business Daily
Search the archive
Key Coverage
Follow IndiaMedToday
Topic
1 article
Glenmark Pharmaceuticals has announced the launch of GLIPIQⓇ (semaglutide) in India for the management of Type 2 Diabetes Mellitus (T2DM), setting a…